The firm's CFO said that the timing of revenue recognition on the Beacon carrier screening test prevented Fulgent from recording revenues from the tests in Q4.
The researchers developed a qPCR test that analyzes microRNAs associated with ovarian cancer and plan to run a retrospective trial of the assay on biobanked samples.
Amoy will supply its CD95 IHC and CpG2 qPCR kits to develop a companion diagnostic for Canbridge's lead product targeting recurrent glioblastoma multiforme.